Effects of Ketamine in Treatment-Refractory Obsessive-Compulsive Disorder

BACKGROUND: Treatments for obsessive-compulsive disorder (OCD) usually lead to incomplete symptom relief and take a long-time to reach full effect. Convergent evidence suggests that glutamate abnormalities contribute to the pathogenesis of OCD. Ketamine is a potent noncompetitive antagonist of the N...

詳細記述

保存先:
書誌詳細
主要な著者: Bloch, Michael H., Wasylink, Suzanne, Landeros-Weisenberger, Angeli, Panza, Kaitlyn E., Billingslea, Eileen, Leckman, James F., Krystal, John H., Bhagwagar, Zubin, Sanacora, Gerard, Pittenger, Christopher
フォーマット: Artigo
言語:Inglês
出版事項: 2012
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3667652/
https://ncbi.nlm.nih.gov/pubmed/22784486
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.biopsych.2012.05.028
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料